InnovAge Holding Corp.
NASDAQ:INNVMedical - Care Facilities
-$0.01 today
- Market cap
- $1.22B
- Beta
- 0.45
- P/E (TTM)
- -55.8
- EPS (TTM)
- -$0.16
Volume 0.52M
Average 0.29M
INNV Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
InnovAge Holding Corp.NASDAQ: INNV
Gross Profit · Q3 FY2026 · quarter ended Mar 2026
Gross profit growth accelerates
Q3 FY2026 gross profit of $56.2M rose 37.9% year over year, ahead of the +31.8% change in trailing-twelve-month gross profit. Sequentially, it rose 17.2% from the prior quarter. Over 3 fiscal years it compounded at +62.9% a year.
Context
- Gross profit amounted to 68.5% of revenue in FY2025, up 51.2 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +37.9% holds above the trailing-twelve-month pace of +31.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 584.79M USD
- Year-over-year change
- +342.8%
- 4-year CAGR
- +37.9%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 584.79M | +342.8% |
| FY2024 | 2024-06-30 | 132.06M | +30.4% |
| FY2023 | 2023-06-30 | 101.29M | -25.2% |
| FY2022 | 2022-06-30 | 135.37M | -16.3% |
| FY2021 | 2021-06-30 | 161.79M | — |
Gross Profit vs competitors
How INNV compares with its peers on the latest reported figures
- INNV's LTM Mar 2026 gross profit of $196.25M is the 6th highest of the 8 companies compared; the peer median is $477.75M.
- Its year-over-year change of +31.8% is the 2nd highest of 8, against a peer median of +5.9%.
- Gross profit amounts to 20.7% of revenue for INNV, versus a peer median of 29.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Oct 2026 | $858.25M | +12.0% | +13.3% | 32.1% | |
| LTM Jun 2026 | $775.91M | +5.9% | +15.6% | 14.1% | |
| LTM Sep 2026 | $506.78M | -12.4% | +15.4% | 32.0% | |
| LTM Jun 2026 | $477.75M | +15.1% | +15.5% | 32.4% | |
| LTM Sep 2026 | $426.54M | -49.7% | +7.9% | 14.5% | |
| LTM Mar 2026 | $196.25M | +31.8% | +62.9% | 20.7% | |
| LTM Mar 2026 | $151.28M | +47.4% | +27.9% | 14.8% | |
| LTM Mar 2026 | -$123.06M | -136.6% | — | 29.9% | |
| Peer median (excluding INNV) | $477.75M | +5.9% | +15.5% | 29.9% | |
Competitors are the stored peer set for INNV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Revenue | 637.8M | 698.64M | 688.09M | 763.86M | 853.7M |
| Cost of Revenue | 476.01M | 563.27M | 586.8M | 631.79M | 268.91M |
| Gross Profit | 161.79M | 135.37M | 101.29M | 132.06M | 584.79M |
| Gross Margin | 25.4% | 19.4% | 14.7% | 17.3% | 68.5% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 154.57M | 125.85M | 135.26M | 136.29M | 150.28M |
| Operating Expenses | 86.96M | 139.78M | 150.68M | 155.24M | 614.55M |
| Depreciation & Amortization | 12.29M | 13.92M | 15.42M | 18.95M | 19.51M |
| EBITDA | (5.89M) | 9.21M | (33.85M) | 1.15M | 3.36M |
| EBITDA Margin | -0.9% | 1.3% | -4.9% | 0.2% | 0.4% |
| Operating Income | 74.82M | (4.41M) | (49.4M) | (23.18M) | (29.76M) |
| Operating Margin | 11.7% | -0.6% | -7.2% | -3.0% | -3.5% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 16.79M | 2.53M | 1.52M | 4.02M | 4.61M |
| Other Income / Expenses | (109.79M) | (2.83M) | (1.4M) | 1.36M | (4.27M) |
| Income Before Tax | (34.97M) | (7.24M) | (50.79M) | (21.82M) | (34.03M) |
| Pre-Tax Margin | -5.5% | -1.0% | -7.4% | -2.9% | -4.0% |
| Income Tax Expense | 9.77M | 723K | (7.24M) | 1.4M | 1.32M |
| Net Income | (43.99M) | (6.52M) | (40.67M) | (21.34M) | (30.31M) |
| Net Margin | -6.9% | -0.9% | -5.9% | -2.8% | -3.6% |
| EPS (Basic) | (0.33) | (0.05) | (0.30) | (0.16) | (0.22) |
| EPS (Diluted) | (0.33) | (0.05) | (0.30) | (0.16) | (0.22) |
| Weighted Avg Shares | 135.52M | 135.52M | 135.59M | 135.9M | 135.39M |
| Weighted Avg Shares (Diluted) | 135.52M | 135.52M | 135.59M | 135.9M | 135.39M |
InnovAge Holding Corp.
NASDAQ:INNV
Intrinsic Alpha fair value
Locked
Current Price
$8.91
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.